p110γ and p110δ Phosphoinositide 3-Kinase Signaling Pathways Synergize to Control Development and Functions of Murine NK Cells
暂无分享,去创建一个
Josef M. Penninger | M. Colonna | J. Penninger | M. Cella | T. Diacovo | S. Gilfillan | I. Turnbull | I. Tassi | Marco Colonna | Marina Cella | Susan Gilfillan | Ilaria Tassi | Thomas G. Diacovo | Isaiah R. Turnbull | Ilaria Tassi
[1] P. Leibson,et al. NKG2D-mediated signaling requires a DAP10-bound Grb2-Vav1 intermediate and phosphatidylinositol-3-kinase in human natural killer cells , 2006, Nature Immunology.
[2] Dianqing Wu,et al. Roles of PLC-β2 and -β3 and PI3Kγ in Chemoattractant-Mediated Signal Transduction , 2000 .
[3] K. Okkenhaug,et al. Impaired B and T Cell Antigen Receptor Signaling in p110δ PI 3-Kinase Mutant Mice , 2002, Science.
[4] D. Fruman,et al. Phosphoinositide 3-kinase: diverse roles in immune cell activation. , 2004, Annual review of immunology.
[5] M. Smyth,et al. CD27 Dissects Mature NK Cells into Two Subsets with Distinct Responsiveness and Migratory Capacity1 , 2006, The Journal of Immunology.
[6] A. Bilancio,et al. Signalling by PI3K isoforms: insights from gene-targeted mice. , 2005, Trends in biochemical sciences.
[7] L. Ashman,et al. Role of c-KIT expression level and phosphatidylinositol 3-kinase activation in survival and proliferative responses of early myeloid cells. , 2006, Cellular signalling.
[8] W. Swat,et al. Differential Requirements for Vav Proteins in DAP10- and ITAM-mediated NK Cell Cytotoxicity , 2004, The Journal of experimental medicine.
[9] K. Okkenhaug,et al. Cutting Edge: Differential Roles for Phosphoinositide 3-Kinases, p110γ and p110δ, in Lymphocyte Chemotaxis and Homing1 , 2004, The Journal of Immunology.
[10] W. Swat,et al. Essential role of PI3Kdelta and PI3Kgamma in thymocyte survival. , 2006, Blood.
[11] M. Waterfield,et al. Synthesis and function of 3-phosphorylated inositol lipids. , 2001, Annual review of biochemistry.
[12] L. Lanier,et al. NKG2D triggers cytotoxicity in mouse NK cells lacking DAP12 or Syk family kinases , 2003, Nature Immunology.
[13] W. Yokoyama,et al. In vivo developmental stages in murine natural killer cell maturation , 2002, Nature Immunology.
[14] L. Eisenlohr,et al. Differential Role of p38 and c-Jun N-Terminal Kinase 1 Mitogen-Activated Protein Kinases in NK Cell Cytotoxicity1 , 2000, The Journal of Immunology.
[15] K. Okkenhaug,et al. p110δ is required for innate immunity to transplantable lymphomas , 2007 .
[16] Vinay Kumar,et al. Murine natural killer cell progenitors and their requirements for development. , 2002, Seminars in immunology.
[17] Eric Vivier,et al. Natural Killer Cell Signaling Pathways , 2004, Science.
[18] Qingxian Lu,et al. Natural killer cell differentiation driven by Tyro3 receptor tyrosine kinases , 2006, Nature Immunology.
[19] Jianfei Yang,et al. Selective Requirement of p38α MAPK in Cytokine-Dependent, but Not Antigen Receptor-Dependent, Th1 Responses1 , 2006, The Journal of Immunology.
[20] J. Penninger,et al. The role of endothelial PI3Kgamma activity in neutrophil trafficking. , 2005, Blood.
[21] A. Cumano,et al. A thymic pathway of mouse natural killer cell development characterized by expression of GATA-3 and CD127 , 2006, Nature Immunology.
[22] R. Vance,et al. Regulation of the natural killer cell receptor repertoire. , 2001, Annual review of immunology.
[23] Chen Dong,et al. MAP kinases in the immune response. , 2002, Annual review of immunology.
[24] P. Leibson,et al. NKG2D-DAP10 triggers human NK cell–mediated killing via a Syk-independent regulatory pathway , 2003, Nature Immunology.
[25] J. Ihle,et al. Essential, Nonredundant Role for the Phosphoinositide 3-Kinase p110δ in Signaling by the B-Cell Receptor Complex , 2002, Molecular and Cellular Biology.
[26] E. Vigorito,et al. Cutting Edge: T Cell Development Requires the Combined Activities of the p110γ and p110δ Catalytic Isoforms of Phosphatidylinositol 3-Kinase1 , 2005, The Journal of Immunology.
[27] Lewis L Lanier,et al. Natural killer cell receptor signaling. , 2003, Current opinion in immunology.
[28] N. Bhat,et al. Regulation of ITAM-positive receptors: role of IL-12 and IL-18. , 2006, Blood.
[29] Silvano Sozzani,et al. Central role for G protein-coupled phosphoinositide 3-kinase γ in inflammation , 2000 .
[30] T. Asano,et al. PI3K-mediated negative feedback regulation of IL-12 production in DCs , 2002, Nature Immunology.
[31] P. Hawkins,et al. p84, a New Gβγ-Activated Regulatory Subunit of the Type IB Phosphoinositide 3-Kinase p110γ , 2005, Current Biology.
[32] S. Ward,et al. Phosphoinositide 3‐kinase: a key biochemical signal for cell migration in response to chemokines , 2000, Immunological reviews.
[33] L. Frati,et al. CD16‐mediated activation of phosphatidylinositol‐3 kinase (Pl‐3K) in human NK cells involves tyrosine phosphorylation of Cbl and its association with Grb2, Shc, pp36 and p85 Pl‐3K subunit , 1998, European journal of immunology.
[34] G. Cavallo,et al. Involvement of phospholipase A2 activation and arachidonic acid metabolism in the cytotoxic functions of rat NK cells. , 1993, Cellular immunology.
[35] L. Eisenlohr,et al. Dependence of both spontaneous and antibody-dependent, granule exocytosis-mediated NK cell cytotoxicity on extracellular signal-regulated kinases. , 1998, Journal of immunology.
[36] R. Abraham,et al. Fc receptor stimulation of phosphatidylinositol 3-kinase in natural killer cells is associated with protein kinase C-independent granule release and cell-mediated cytotoxicity , 1994, The Journal of experimental medicine.
[37] James J. Campbell,et al. Sustained Activation of Cell Adhesion Is a Differentially Regulated Process in B Lymphopoiesis , 2003, The Journal of experimental medicine.
[38] Q. Jiang,et al. Cell biology of IL-7, a key lymphotrophin. , 2005, Cytokine & growth factor reviews.
[39] S. Koyasu. The role of PI3K in immune cells , 2003, Nature Immunology.
[40] yang-xin fu,et al. A role for lymphotoxin in the acquisition of Ly49 receptors during NK cell development , 2004, European journal of immunology.
[41] W. Dai,et al. Transforming activity of receptor tyrosine kinase tyro3 is mediated, at least in part, by the PI3 kinase-signaling pathway. , 2000, Blood.
[42] W L Stanford,et al. Function of PI3Kgamma in thymocyte development, T cell activation, and neutrophil migration. , 2000, Science.
[43] B. Zhong,et al. Syk Regulation of Phosphoinositide 3-Kinase-Dependent NK Cell Function1 , 2002, The Journal of Immunology.
[44] E. Vigorito,et al. A Crucial Role for the p110δ Subunit of Phosphatidylinositol 3-Kinase in B Cell Development and Activation , 2002, The Journal of experimental medicine.
[45] A. Cope,et al. Stabilization of IFN-γ mRNA by MAPK p38 in IL-12– and IL-18–stimulated human NK cells , 2005 .
[46] S. Ward,et al. Optimal Chemotactic Responses of Leukemic T Cells to Stromal Cell-Derived Factor-1 Requires the Activation of Both Class IA and IB Phosphoinositide 3-Kinases1 , 2003, The Journal of Immunology.
[47] C. Biron,et al. Natural killer cells in antiviral defense: function and regulation by innate cytokines. , 1999, Annual review of immunology.
[48] Seung Yong Park,et al. Association with FcRγ Is Essential for Activation Signal through NKR-P1 (CD161) in Natural Killer (NK) Cells and NK1.1+ T Cells , 1997, The Journal of experimental medicine.
[49] J. P. Santo. NATURAL KILLER CELL DEVELOPMENTAL PATHWAYS: A Question of Balance , 2006 .
[50] Emilio Hirsch,et al. Blockade of PI3Kγ suppresses joint inflammation and damage in mouse models of rheumatoid arthritis , 2005, Nature Medicine.
[51] B. Zhong,et al. Pivotal role of phosphoinositide-3 kinase in regulation of cytotoxicity in natural killer cells , 2000, Nature Immunology.
[52] L. Cironi,et al. NKR-P1A stimulation of arachidonate-generating enzymes in rat NK cells is associated with granule release and cytotoxic activity. , 1997, Journal of immunology.
[53] B. Zhong,et al. Functional role of phosphatidylinositol 3-kinase in direct tumor lysis by human natural killer cells. , 2002, Immunobiology.
[54] A. Kelso,et al. Differential activation of T cell cytokine production by the extracellular signal‐regulated kinase (ERK) signaling pathway , 1996, European journal of immunology.